Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth (Status and Outlook) 2019-2024

Published On: July 2019 | Report ID: 172890 | Category: Pharmaceuticals and HealthcarePages: 132

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.

According to this study, over the next five years the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market by product type, application, key companies and key regions.

This study considers the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

Aspirin

Ibuprofen

Celecoxib

Others

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

Drug Store

Hospital Pharmacies

Online

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Roche (including Genentech)

Amgen

B-MS

Merck

Pfizer

Novartis

Eli Lilly and Company

Johnson & Johnson

GSK

Sanofi

Boehringer Ingelheim

Zhejiang Jiuzhou Pharmaceutical Co

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market by identifying its various subsegments.

Focuses on the key global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report (Status and Outlook)

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2014-2024

2.1.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Region

2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type

2.2.1 Aspirin

2.2.2 Ibuprofen

2.2.3 Naproxen

2.2.4 Celecoxib

2.2.5 Others

2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

2.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2014-2019)

2.3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (2014-2019)

2.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application

2.4.1 Drug Store

2.4.2 Hospital Pharmacies

2.4.3 Online

2.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

2.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2014-2019)

2.5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application (2014-2019)

3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Players

3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Players

3.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Players (2017-2019)

3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Players (2017-2019)

3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Regions

4.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions

4.2 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth

4.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth

4.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth

4.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth

5 Americas

5.1 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Countries

5.2 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

5.3 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Countries

6.2 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

6.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries

7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries

8.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

8.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast

10.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast (2019-2024)

10.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Regions

10.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Regions (2019-2024)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Type

10.8 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Application

11 Key Players Analysis

11.1 Roche (including Genentech)

11.1.1 Company Details

11.1.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.1.3 Roche (including Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.1.4 Main Business Overview

11.1.5 Roche (including Genentech) News

11.2 Amgen

11.2.1 Company Details

11.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.2.4 Main Business Overview

11.2.5 Amgen News

11.3 B-MS

11.3.1 Company Details

11.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.3.4 Main Business Overview

11.3.5 B-MS News

11.4 Merck

11.4.1 Company Details

11.4.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.4.4 Main Business Overview

11.4.5 Merck News

11.5 Pfizer

11.5.1 Company Details

11.5.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.5.4 Main Business Overview

11.5.5 Pfizer News

11.6 Novartis

11.6.1 Company Details

11.6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.6.4 Main Business Overview

11.6.5 Novartis News

11.7 Eli Lilly and Company

11.7.1 Company Details

11.7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.7.4 Main Business Overview

11.7.5 Eli Lilly and Company News

11.8 Johnson & Johnson

11.8.1 Company Details

11.8.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.8.4 Main Business Overview

11.8.5 Johnson & Johnson News

11.9 GSK

11.9.1 Company Details

11.9.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.9.4 Main Business Overview

11.9.5 GSK News

11.10 Sanofi

11.10.1 Company Details

11.10.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered

11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)

11.10.4 Main Business Overview

11.10.5 Sanofi News

11.11 Boehringer Ingelheim

11.12 Zhejiang Jiuzhou Pharmaceutical Co

12 Research Findings and Conclusion

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@mrinsights.biz

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.